The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.30
Bid: 19.00
Ask: 19.96
Change: -0.20 (-1.03%)
Spread: 0.96 (5.053%)
Open: 20.00
High: 20.00
Low: 18.66
Prev. Close: 19.50
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Commercialisation Strategy in Display

31 Mar 2016 07:00

RNS Number : 6262T
Nanoco Group PLC
31 March 2016
 

For immediate release

31 March 2016

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Adopts New Commercialisation Strategy in Display

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that it has mutually agreed with The Dow Chemical Company (NYSE: DOW) ("Dow") to modify its licence agreement for Nanoco's cadmium-free quantum dot technology. Under the modified agreement, Dow has non-exclusive rights for the sale, marketing and manufacture of Nanoco's quantum dot technology for use in display applications while Nanoco is free to pursue a range of routes to market.

This new display strategy will allow Nanoco to maximise the roll-out of its technology and give the Company greater control over the commercialisation of its intellectual property in the display industry. In the near term the Company intends to develop new partnerships to serve the display sector as well as to manufacture, market and sell its cadmium-free quantum dot products directly from the Company's own plant in Runcorn.

 

Amid a very positive market backdrop it is an exciting time for the Company to gain further control of its strategy in the display industry. Cadmium-free quantum dots are expected to be at the centre of a major, emerging industry in consumer electronics, with DisplaySearch forecasting that 18.7 million quantum dot TVs will be shipped in 2018.

 

As a result of changing the Dow agreement to non-exclusive, Nanoco will receive a lower royalty rate from Dow on Dow's sales of cadmium-free quantum dot products and the Company will not receive earn-out income from Dow. Nanoco-generated sales of cadmium-free quantum dots will be satisfied by production from the Company's own plant in Runcorn. All other terms of the agreement with Dow remain unchanged. It is anticipated that Nanoco's revenues in the current financial year will be lower than previously expected as a result of this new agreement. However, the Company anticipates that it will lead to higher revenues in future years.

 

The change in the licensing agreement does not affect commercial production of Dow's TREVISTAâ„¢ cadmium-free quantum dots at Dow's large scale quantum dot facility in Cheonan, South Korea, which is now supplying sample material to meet potential customers' requirements in line with the timetable indicated in Nanoco's AGM statement issued in December 2015.

 

"Nanoco's cadmium-free quantum dot technology continues to fit well with what our customers want and with our desire to develop products and services that are more sustainable for the future," said Andrew Lee, Global Business Director, Dow Display Technologies. "We are pleased that we can bring consistent, reliable, high-volume supply of our TREVISTAâ„¢ quantum dots based on Nanoco's cadmium-free technology to the market."

 

Michael Edelman, Nanoco's CEO, commented: "We now have a multifaceted strategy in display in which we have a non-exclusive licence agreement with Dow along with the opportunity to form new partnerships and to work independently. We believe this is a very significant development for Nanoco as we are gaining greater control over the commercialisation of our technology in display against a very positive market backdrop."

 

Nanoco intends to release its interim results for the six months ended 31 January 2016 on 12 April 2016.

 

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron DuncanMark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has a licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGFFMGGGVZZ
Date   Source Headline
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension
28th May 20207:00 amRNSQuantum Dot Material Supply Agreement
30th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
30th Apr 20207:00 amRNSInterim Results
30th Apr 20207:00 amRNSTermination of Formal Sale Process
29th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
28th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
27th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.